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Abstract
Pintos, M.E.; Posik, D.M.; Bonzo, E.; Perfumo, C.J.; Arauz, M.S.: Swine hemoplasmosis 
detected in farms o f Argentina by a new nested PCR assay. Rev. Vet. 32: 2, 196-201, 2021. 
Swine hemoplasmosis or swine infectious anemia is a worldwide distribution disease caused 
by the hemotropic mycoplasmas Mycoplasma suis and Mycoplasma parvum. The aim of this 
study was to determine the presence of M. suis-M. parvum infection in subclinical pigs from 
herds of Buenos Aires province, Argentina, by means of new nested PCR. The PCR assay 
primers were designed based on the 16S ribosomal gene sequences of swine hemoplasmas 
available at GenBank. To standardize the assay, pig blood samples positive for hemoplasma 
by May Grünwald-Giemsa (MGG) stained blood smears were used. A total of 482 pig blood 
samples were analyzed. A 32% (154/482) of MGG stained blood smears were positive to M. 
suis o M. parvum. From these 154 samples, 47% (72/154) were positive by PCR. Sequences of 
PCR products amplified with these primers always showed identity with M. suisor M. parvum, 
validating their specificity and highlighting the unspecific amplification with hemoplasmas of 
other species. This is the first assay designed in Argentina to identify M. suis and M. parvum. 
However, considering the advances in the knowledge of the genome of hemoplasmas world­
wide, further studies should be performed to standardize new assays for the diagnosis of swine 
hemoplasmosis in Argentina.
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Resumen
Pintos, M.E.; Posik, D.M.; Bonzo, E.; Perfumo, C.J.; Arauz, M.S.: Hemoplasmosis por­
cina detectada en granjas de Argentina mediante un nuevo ensayo de PCR anidada. Rev. 
Vet. 32: 2, 196-201, 2021. La hemoplasmosis porcina o anemia infecciosa de los cerdos es una 
enfermedad de distribución mundial causada por Mycoplasma suis y Mycoplasma parvum. El 
objetivo de este estudio fue determinar la presencia de infecciones subclínicas con M.suis-M. 
parvum en cerdos provenientes de granjas de la Provincia de Buenos Aires, Argentina, por 
medio de una nueva PCR anidada. Para el diseño de los primers se utilizaron las secuencias del 
gen ribosomal 16S de los hemoplasmas disponibles en el GenBank. La técnica fue estandariza­
da con muestras de porcinos positivos a hemoplasmas seleccionados mediante la observación 
en frotis sanguíneos teñidos conMayGrünwald-Giemsa (MGG). Se analizaron un total de 482 
muestras de sangre de cerdos, un 32% (154/482) de los frotis sanguíneos fueron positivos a M. 
suis o M. parvum con la tinción de MayGrünwald-Giemsa y de estas 154 muestras un 47% 
(72/154) fueron positivas por PCR. Por secuenciación se confirmó que los productos ampli­
ficados con estos primers siempre mostraron identidad con M. suis así como con M. parvum, 
validando su especificidad de especie y resaltando la no amplificación con ningún otro hemo­
plasma. El diseño de esta técnica fue el primero realizado en nuestro país para identificar M. 
suis-M. parvum. Considerando los avances en el conocimiento del genoma de los hemoplasmas 
a nivel mundial, se deberá seguir trabajando en la estandarización de nuevas técnicas de diag­
nóstico de hemoplasmosis porcina en Argentina.
Palabras clave: porcino, hemoplasma, PCR anidada, Argentina.
in t r o d u c t io n
Swine hemoplasmosis or swine infectious anemia, 
is a disease caused by the hemotropic mycoplasma My-
coplasma suis and Mycoplasma parvum. These bacteria
are classified within the mollicutes group and belong to 
the group of non-culturable hemoplasmas, adhered to 
the surface of porcine erythrocytes. Porcine hemoplas­
mosis is diagnosed on the basis of epidemiological and
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clinical signs, hematological and biochemical studies 
and by polymerase chain reaction (PCR) assay 10 23 .
M. suis causes hemolytic anemia in domestic pigs 
producing great economic losses and is a worldwide 
importance disease. In Argentina, M. suis infection was 
first reported in the Santa Fe province in 1986, in a pig 
with presumptive diagnosis of pneumonía while there is 
no data of M. parvum infections in our country 1 12.
M. suis infection has two forms of presentation: 
acute and chronic. In the former, the most impor- 
tant clinical signs are fever, severe anemia and death, 
whereas in the latter, the most important signs are mild 
anemia in maternity or nursery piglets, growth retarda- 
tion in post-weaning and fattening pigs, reproductive 
failures, postpartum dysgalactia syndrome, and necro­
sis in the ears of sows 10 25 30 .
It is pleomorphic, about 0.2 to 2.5 ^m in diameter, 
and can occur in coccoid or rings forms. M. parvum 
is a non-pathogenic porcine bacterium characterized 
generally by the absence clinical signs. This bacterium 
often accumulates in large quantities in a single eryth- 
rocyte, however only a few red blood cells are infected. 
It has a size <0.5 ^m 4 .
Considering M. suis produce a decrease of grow- 
ing rate, a higher susceptibility to secondary infections 
of respiratory and enteric system, production decrease 
and thus great economic losses 24 , the aim of this study 
was to determine the presence of hemoplasmas in pigs 
from herds of Buenos Aires province, Argentina, by 
means of a designed nested PCR assay.
m a t e r ia l  a n d  m e t h o d s
Design o f primers to identify porcine hemoplasmas 
The following hemotropic mycoplasmas 16S ribo­
somal gene sequences from GenBank were used for 
primers design: M. coccoides, M. haemocanis, M. hae- 
mofelis, M. haemomuris, M. ovis, M. wenyonii, “Candi- 
datus M. haemominutum”, “Candidatus M. haemopar- 
vum”, “Candidatus M. turicensis”, M. suis and M. par­
vum. ClustalX 2.1 software was used to build multiple 
alignments for each species using all the sequences 
so far available at GenBank 13 . For each alignment, 
a consensus sequence with 100% inclusion threshold 
was created using the BioEdit program 8 , so that the 
consensus sequences showed all the possible variants 
and not the most frequent one. The positions of the 
alignments in which the sequences presented nucleo- 
tide variability were represented in the consensus with 
the symbology for ambiguity of bases recommended 
by Cornish Bowden 2 . Subsequently, the consensuses 
of each species were aligned with ClustalX 2.1. In this 
last alignment, regions unique for porcine hemoplas­




MSuisEP1r 5’-CACCGCGAACACTTGTTAAGCAARTA-3’ and 
MSuisEP2r 5’-AYTTTTAACAAKGRATACACAYTTCA-3’),
using Primer3 program 26, 27. To include all the geno- 
typic variants reported, the design included degener­
ate primers to amplify any of the possible genotypes 
regardless of their frequency of appearance.
Experimental design to obtain positive and negative 
controls o f porcine hemoplasmas
Controls were kindly provided by investigator 20 
from the Institute of Porcinotecnia, Ministry of Produc­
tion, Santa Fe province, Argentina. Our own controls 
were also obtained through a modified Groebel experi­
mental model, based on experimental reproduction of the 
disease 7 . We worked with four five-week-old females 
from a farm located in Buenos Aires province. Haemato- 
logical and PCR studies were performed to identify two 
of the females as positive to porcine hemoplasma and 
two as negative 18 . Animal experimental protocols were 
approved by the Animal Care and Use Committee of the 
School o f Veterinary Sciences of the National Univer- 
sity o f La Plata, Argentina (protocol number 18.1.11. res. 
129/09) and the experiments were performed according 
to our institutional ethical rules and laws 19 .
DNA extraction from porcine hemoplasmas
DNA from 100 ^l of whole EDTA-blood was ex- 
tracted with DNAzol (Invitrogen, USA), according to 
the supplier’s manual. The concentration and purity of 
the DNA samples were determined spectrophotometri- 
cally by measuring absorbance at 260 nm and 280 nm 
with a NanoVueTM (GE Healthcare, USA). DNA sam­
ples were stored at -20°C until the PCR was performed.
PCR amplification o f porcine hemoplasmas
PCR reactions contained 0.5 U/^l FIRE Pol Ther- 
mostable DNA Polymerase (Solis, Biodyne, Estonia), 1 
X Buffer, 2 mM MgCl2, 0.25 mMdNTPs, 0.5 mM of 
each primer and nuclease-free water in 20 ^l final vol- 
ume. Tests were performed on a MyCycler™ thermal 
cycler (Bio-Rad, USA). The cycling program consisted 
of 2 min denaturation at 92°C, followed by 35 cycles of 
30 s denaturation at 92°C, 30 s annealing at 45°C, and 
40 s extension at 72°C, finishing with a 4-min exten- 
sion step at 72°C. The nested PCR for swine hemoplas­
mas consisted of two amplification rounds, using the 
same conditions and cycling program described above. 
For the first round, 2 ^l of template DNA was used, 
whereas for the second round, 1 ^l of the first round of 
amplification was used as template. The second round 
amplification was analyzed by 1% agarose gel electro- 
phoresis stained with ethidium bromide (1 ^g/ml). The 
controls mentioned above 20 and our own controls were 
used as positive and negative controls. To detect cross- 
amplification with related and other species M. coccoi- 
des, M. haemocanis, M. haemofelis, M. haemomuris, M. 
ovis, M. wenyonii and healthy pig DNA were used. In 
order to detect PCR inhibitors in negative amplifica- 
tion samples, an internal control was used to amplify 
a porcine mitochondrial Cytb gene fragment using the 
Kocher primers describe 11 .
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Sequencing
PCR products were purified with polyethylene gly- 
col according to the Travis Glennprotocol (www.mcdb. 
lsa.umich.edu/labs/olsen/files/PCR.pdf). The amplifi­
cation products were sequenced in a MegaBACE 1000 
DNA Sequencing System (GE Healthcare, USA) in both 
senses. Sequences were compared in GenBank through 
the Basic Local Alignment Search Tool (BLAST, http:// 
www.ncbi.nlm.nih.gov/).
Samples used for the standardization o f the assay
To standardize the assay, we worked with blood 
samples from different animal species admitted to the 
Central Laboratory Service of the School Hospital of 
the Faculty of Veterinary Sciences of the Universidad 
Nacional de La Plata, La Plata, Argentina, as well as 
from blood samples from rats and mice from the Lab- 
oratory Animal facilities of the same Faculty, 102 of 
which were selected because their smears stained with 
May Grünwald-Giemsa (Merk, USA) were positive for 
hemoplasma. Six of the samples were from rats, six 
from mice, eight from dogs, eight from cats, six from 
sheep, four from cattle and sixty-four from pigs. Blood 
samples in which coccoid forms adhered to the eryth- 
rocyte membrane were observed and which also pre­
sented alterations in the erythrocyte series (anisocyto- 
sis, poikilocytosis, polychromasia or target cell) were 
considered positive to hemoplasma (Figure 1).
Quality control
During the standardization stage and the samples 
processing, both the quality and calibration of the 
laboratory equipment were controlled. The analytical 
repeatability of the assay was estimated using different 
cyclers, DNA concentrations, temperatures, number of 
cycles, temperature gradients and commercial brands 
of Taq polymerase. Positive and negative reference 
samples were tested along with the unknown samples 
in each run. Throughout the study, the repeatability 
and precision of the assay were constantly monitored 
in all the samples processed.
Figure 1. Smears stained with May Grünwald-Giemsa 
from a porcine sample. Hemoplasmas were detected 
free in the plasma and on the surface of erythrocytes 
(indicated with black arrows).
Samples used for diagnosis o f swine hemoplasmosis 
in farms o f Argentina
The selection criteria for farms and pigs in each 
farm were based on accessibility and advisability. The 
study comprised 30 herds from farms of Buenos Ai­
res province. A total 482 pig blood samples from ap- 
parently healthy animals were obtained from different 
categories.
Statistical analysis
An exploratory analysis of the data obtained was 
carried out with the EpiInfo™ 7.2.0.1 software (CDC) 
and InfoStat version 2018 3 .
RESULTS
For DNA extraction two alternative protocols 
were tested. One using silica oxide and a commercial 
one (DNAzol, Invitrogen®). In the comparison, with 
DNAzol it was necessary a lower initial blood vol- 
ume and the DNA were of better quality, had smaller 
amount of inhibitors and result in a homogeneous yield. 
Because of this, DNAzol was the method of choice.
All possible combinations of primers were tested 
to amplify the 16S gene fragment of hemotropic myco- 
plasmas in a single round of PCR. As no amplification 
products were detected, it was necessary to perform a 
nested PCR by using the primers MSuisEP1f and MSu- 
isEP1r as external primers and MSuis-EP2f and MSuis- 
EP2r as internal primers.
With this combination, a fragment of an approxi- 
mate size of 360 bp was amplified in the second round 
(Figure 2). This methodology allowed to increase the 
sensitivity and to obtain amplification products, as well 
as to increase the specificity of the assay.
The amplified products, obtained from the positive 
controls to hemotropic mycoplasmas during the experi­
mental reproduction of the disease, and the intensity in­
crease of the amplified band along 45 days, are shown 
in Figure 3.
Figure 2. Nested PCR with specific primers for 
M.suis-M.parvum. Agarose gel electrophoresis of 
fragments amplified in the nested PCR with primers 
for Msu-is-Mparvum. The size of the amplification 
product was approximately 360 bp. Lane 1: marker 
pcDNA/HinfI (1129, 517, 453, 396 and 356 bp). Lanes 
2 to 14: samples from pigs. Lane 15: positive control. 
Lane 16: negative control.
Pintos M.E. et al.: Hemoplasmosis porcina. Rev. Vet. 32: 2, 196-201, 2021 199
Lane 10 of this figure, which 
corresponds to day 16, shows the 
greatest amplification, which indi- 
rectly corresponds to the peak of 
bacteremia (Figure 3). The ampli- 
fication products from the second 
amplification round showed a 360 
pb size estimated from the molec­
ular size marker.
The sequences of the amplifi­
cation products allowed to confirm the identity of por­
cine hemoplasmas and to confirm that the 366-bp frag- 
ment was coincident with the expected size predicted 
by bioinformatics analysis.
The amplified fragments from 10 positive samples 
were sequenced and the sequences compared with the 
GenBank database using the Blast algorithm. Products 
showed 100% identity to the 16S rRNA sequence de- 
scribed for porcine hemoplasmas.
No cross amplification was detected when M. coc- 
coides, M. haemocanis, M. haemofelis, M. haemomuris, 
M. ovis, M. wenyonii and healthy pig DNA were used. 
The analysis of the 482 pig blood samples from the 30 
farms of Argentina by using this technique showed that 
36% (172/482) of the animals were positive for either 
M.suis or M.parvum.
The hematological studies by MGG showed a 32% 
(154/482) positive to porcine hemoplasmas. As have 
been mentioned, just a 47% of the samples analyzed by 
MGG were positives by PCR (Table 1).
In order to avoid false negative, an internal ampli­
fication control was used to amplify a 258 bp porcine 
mitochondrial DNA fragment using the Kocher et al. 11 
primers. All the hemoplasma negative samples amplify 
this control fragment confirming PCR inhibitors ab- 
sence in DNA samples (Figure 4).






M.suis-M.parvum MGG (+) 72 (15%) 82 (17%) 154 (32%)
M.suis-M.parvum MGG (-) 100 (21%) 228 (47%) 328 (68%)
total 172 (36%) 310 (64%) 482 (100%)
DISCUSSION
In his hematological studies, Stadler y col. 23 24 
from infected animals, splenectomized and no splenec- 
tomized, used a MGG stain as complementary diagno­
sis of anemia characterization, describing the presence 
of hemoplasmas as responsible of cause the disease. 
The hematological findings in our study agree with this 
author.
This technique has a low sensitivity since micro- 
organism only are visible when there is an important 
peripheral blood bacterial load and subjective since are 
very depending of the technician experience.
Frequently leading to an under diagnosed disease. 
Due to the inability to cultivate hemotropic myco- 
plasms, reliable prevalence data for porcine hemoplas­
mas are rare and restricted to the post-PCR era 24.
As have been mentioned, just a 47% of the samples 
analyzed by MGG were positives by PCR. Although 
17% were positive by MGG not by PCR, this may be- 
cause this assay was designed to M.suis-M.parvum 
specificity it has to take into account recent studies 
that suggests the presence of non-classified new my-
coplasma 6, 22 .
False positives observed in blood smears may be 
due these novel mycoplasmas that can be observed 
with MMG technique but cannot be detected by PCR 
due to the primer were designed to amplified M.suis- 
M.parvum DNA or may be due the essay subjectivity 
during smear reading. Though the same cannot be use
Figure 3. Nested PCR with specific primers for M.suis- 
M.parvum. Agarose gel elec-trophoresis of fragments 
amplified in the nested PCR with primers for M.suis- 
M  parvum. The size of the amplification product was 
approximately 360 bp. Lane 1: marker pcDNA/HinfI 
(1129, 517, 453, 396 and 356 bp). Lanes 2 to 12: 0, 2, 4, 6, 
8, 10, 12, 14, 16, 18 and 20 days post-surgery. Lane 13: 
negative control. Lane 14: positive control.
Figure 4. Agarose gel electrophoresis of the frag­
ments amplified in the nested PCR with 
the primers by Kocher et al (1989). Lane 1 to 10 and 
12: samples from pigs. Lane 11: ne­
gative control. Lane 12: positive control. Lane 13: 
marker pig mitochondrial DNA fragment.
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as sieve test, it should be noted that is a low cost, very 
practical and useful test to evaluate blood cells.
In addition, the alterations that can be found in 
anemia patients are of great help for diagnosis and 
evolution of clinic or subclinical conditions that can 
be observed in animals with porcine hemoplasmosis. 
Although the nested PCR is a qualitative technique and 
can produce false negatives, these are due its detection 
limits.
These data cannot be compared with those from 
other works because is the first time that simultane- 
ously haematological and molecular biology studies 
are done in naturally infected animals by porcine he- 
moplasmas.
Protocols published by investigators 9 14 cannot be 
reproduced in our laboratory, for that reason it was 
necessary to design new primers to amplify porcine 
hemoplasma DNA. As porcine micoplasmas cannot be 
cultured 10 15 16 21 and since this study was carried out 
using a qualitative method of PCR, the sensitivity of 
the diagnostic test could not be determined.
The DNA sequences from the amplified fragments 
always showed similarity to M.suis or M.parvum. 
When hemotropic mycoplasma DNA obtained from a 
variety of species other than pig were tested, it could 
not be amplified confirming the specificity of the assay. 
The results obtained with the proper positive and nega- 
tive controls in the experimental reproduction of the 
disease, coincided with those obtained with the con- 
trols provided 17 , in the multiple amplifications carried 
out (Figure 3), showing high repeatability.
When the species-specific primers of M.suis were 
originally designed, it was thought that M.parvum and 
M. suis were a single species that changed shape and size 
as it matured 20 . Other authors reported the existence of 
two genetic clusters among swine hemoplasmas, repre- 
senting M.suis and a provisional M.parvum 28 .
After the genome sequencing of M.parvum in 2013, 
M.parvum and M.suis were classified as different spe­
cies 4 5 . Therefore, the results obtained with the primers 
here designed allow inferring that they amplify both 
M.suis and M.parvum indistinctly. The comparison of 
the sequences of the amplified fragment between the 
two species showed that there are no unique or specific 
nucleotide to distinguish between species.
This difference does not exist in our alignments in 
the rest of the 16S gene, as mentioned by other research- 
ers 6 22 . In 2012, Watanabe designed a real-time PCR by 
using 16 rRNA gene primers for porcine hemoplasmas. 
However, our alignments allowed us to observe that the 
specific primers for M.parvum published 29 also ampli­
fied several strains of M.suis.
This led us to conclude that their results should be 
revised and that those primers are not useful to differ- 
entiate strains accurately and should thus not be used. 
Recently was reported a novel hemoplasma species 
in Chinese pigs 6 . Although the primers designed for 
M.suis or M.parvum may not amplify this species, the 
novel hemoplasma was not detected in pig samples
from Argentina with universal primers for hemoplas­
mas (data not shown).
In conclusion, the results of our work showed the 
nested PCR here designed was a useful, repeatable and 
reliable technique to detect swine hemotropic myco- 
plasma in pigs. Sequencing confirmed that our prim­
ers always amplified M.suis or M.parvum, validating 
its specificity for these two species and its repeatability.
However, it would be necessary to design a new as­
say based on different regions of the genome to allow 
identifying these hemoplasmas as different species. It 
should also be taken into account these new hemoplas­
mas founded in other countries especially at the time to 
design new primers for the diagnosis of this bacteria in 
our country farms.
In addition, it is suggested to implement more ex- 
haustive controls in cleanliness and disinfection of the 
establishments to reduce the presence of hematopha- 
gous vectors.
This is the first time that a nested PCR specific 
for porcine hemoplasmas (M.suis or M.parvum) is de- 
signed and developed in Argentina.
However, due to the advances in the knowledge of 
the genome of hemoplasmas worldwide, further studies 
on the standardization of new diagnostic assays should 
be conducted.
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